Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Moustafa Gabr

Assistant Professor

Weill Cornell Medicine

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Biochemistry

30%

Pharmaceutical Chemistry

50%

Assay Development

20%

Chemical Biology

20%

Immunomodulation

20%

Molecular Docking

20%

Ligand Design

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles20

Discovery and validation of LAGi-DEL: A nanomolar LAG-3 inhibitor that reverses immune suppression in tumor-immune co-culture models

Article Link

Year:

2026

Designing immunity with cytokines: A logic-based framework for programmable CAR therapies

Article Link

Year:

2025

CHI3L1-targeted small molecules as glioblastoma therapies: Virtual screening-based discovery, biophysical validation, pharmacokinetic profiling, and evaluation in glioblastoma spheroids

Article Link

Year:

2025

Lead optimization of a CHI3L1 inhibitor for Glioblastoma: Enhanced target engagement, pharmacokinetics, and efficacy in 3D spheroid models

Article Link

Year:

2025

First-in-class dual inhibitors of MASTL and Aurora A kinase: Discovery of selective cyclohexa[b]thiophenes with potent anticancer activity

Article Link

Year:

2025

Orthogonal temperature-related intensity change (TRIC) and TR-FRET as a high-throughput screening platform for the discovery of SLIT2 binders: A proof-of-concept approach

Article Link

Year:

2025

Structure-Based Virtual Screening Identifies Potent CD28 Inhibitors That Suppress T Cell Co-stimulation in Cellular and Mucosal Models

Article Link

Year:

2025

TREM2 hit discovery using temperature-related intensity change (TRIC) technology: A proof-of-concept high-throughput screening approach

Article Link

Year:

2025

Temperature-related intensity change (TRIC)-based high-throughput screening enables the discovery of small molecule CD28 binders

Article Link

Year:

2025

Discovery and Optimization of LAG-3-Targeted Small Molecules via DNA-Encoded Chemical Library (DEL) Screening for Cancer Immunotherapy

Article Link

Year:

2025

Discovery of Small-Molecule TIM-3 Inhibitors for Acute Myeloid Leukemia Using Pharmacophore-Based Virtual Screening

Article Link

Year:

2023

Development of a high-throughput TR-FRET screening assay for LAG-3/FGL1 interaction

Article Link

Year:

2023

Discovery of First-in-Class Small Molecule Inhibitors of Lymphocyte Activation Gene 3 (LAG-3)

Article Link

Year:

2023

Gut Microbial-Derived Metabolites as Immune Modulators of T Helper 17 and Regulatory T Cells

Article Link

Year:

2023

Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for <sup>203</sup>Pb and <sup>212</sup>Pb-Based Theranostics

Article Link

Year:

2023

First-in-class small molecule inhibitors of ICOS/ICOSL interaction as a novel class of immunomodulators

Article Link

Year:

2023

Discovery of novel 6-hydroxybenzothiazole urea derivatives as dual Dyrk1A/α-synuclein aggregation inhibitors with neuroprotective effects

Article Link

Year:

2022

AIE Luminogens as Versatile Bioprobes

Article Link

Year:

2021

Peptidomimetic‐based approach toward inhibitors of microbial trimethylamine lyases

Article Link

Year:

2021

Mechanism of zinc ejection by disulfiram in nonstructural protein 5A

Article Link

Year:

2021

Collaborators3

F. Christopher Pigge

Iowa State University

UNITED STATES

Walter Becker

Medizinische Fakultät der RWTH Aachen

GERMANY

Gerhard Wolber

Professor

Freie Universität Berlin

GERMANY

How do I reach out?

Meet Kite AI